Kenneth L. Horton

2013

In 2013, Kenneth L. Horton earned a total compensation of $4.5M as Former EVP & Chief Legal Officer at Vertex Pharmaceuticals, a 62% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$439,425
Option Awards$3,077,513
Salary$465,000
Stock Awards$544,988
Other$12,625
Total$4,539,551

Horton received $3.1M in option awards, accounting for 68% of the total pay in 2013.

Horton also received $439.4K in non-equity incentive plan, $465K in salary, $545K in stock awards and $12.6K in other compensation.

Rankings

In 2013, Kenneth L. Horton's compensation ranked 1,458th out of 12,286 executives tracked by ExecPay. In other words, Horton earned more than 88.1% of executives.

ClassificationRankingPercentile
All
1,458
out of 12,286
88th
Division
Manufacturing
471
out of 4,614
90th
Major group
Chemicals And Allied Products
126
out of 1,466
91st
Industry group
Drugs
84
out of 1,160
93rd
Industry
Pharmaceutical Preparations
75
out of 890
92nd
Source: SEC filing on April 30, 2015.

Horton's colleagues

We found four more compensation records of executives who worked with Kenneth L. Horton at Vertex Pharmaceuticals in 2013.

2013

Jeffrey Leiden

Vertex Pharmaceuticals

Chief Executive Officer

2013

Stuart Arbuckle

Vertex Pharmaceuticals

EVP & Chief Commercial Officer

2013

Ian Smith

Vertex Pharmaceuticals

Chief Financial Officer

2013

Peter Mueller

Vertex Pharmaceuticals

Chief Scientific Officer

In-depth

You may also like